The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/Objective-The central nervous system is thought to influence the regulation of the cardiovascular system in response to humoral and neural signals from peripheral tissues, but our understanding of the molecular mechanisms involved is still quite limited. Methods and Results-Here, we demonstrate a central nervous system-mediated mechanism by which brain-derived neurotrophic factor (BDNF) has a protective effect against cardiac remodeling after myocardial infarction (MI). We generated conditional BDNF knockout mice, in which expression of BDNF was systemically reduced, by using the inducible Cre-loxP system. Two weeks after MI was induced surgically in these mice, systolic function was significantly impaired and cardiac size was markedly increased in conditional BDNF knockout mice compared with controls.
M yocardial infarction (MI) is the most common cause of cardiac morbidity and mortality in many countries, and left ventricular remodeling after MI is an important phenomenon because it causes progression to heart failure. Although numerous therapeutic strategies have been developed, death from heart failure is still a serious problem worldwide. 1 Brainderived neurotrophic factor (BDNF) was originally discovered in the brain as a member of the neurotrophin family, and is known to have neurotrophic functions that are crucial in both the embryonic and adult brain. 2, 3 BDNF specifically binds to the tropomyocin-related kinase receptor B (TrkB) and activates many intracellular signaling pathways, thereby affecting the development and function of the nervous system. 2, 4 
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Accumulating evidence suggests that BDNF is also required for the development of the cardiovascular system. BDNF-deficient mice develop atrial septal defects and also die from diffuse intramyocardial hemorrhage attributable to impaired endothelial adhesion. 5 It has been reported that transcriptional activation of TrkB is crucial for coronary vessel development. 6 The previous studies have revealed that BDNF acts on endothelial cells and promotes neovascularization in response to hypoxic stimuli via the Akt pathway. 7, 8 In addition to a direct action on local endothelial cells, BDNF enhances capillary formation by recruiting proangiogenic hematopoietic cells, 9 indicating that it has a critical role in maintaining the integrity of the vascular system in adults. However, it remains unclear whether BDNF is involved in the pathophysiology of adult cardiac diseases such as MI.
In the present study, we demonstrate a cardioprotective role of the BDNF-TrkB axis by using a variety of genetic mouse models. Systemic deletion of BDNF or disruption of TrkB in the heart led to exacerbation of cardiac dysfunction after MI. The plasma levels of BDNF were markedly increased after MI, and this increase was associated with the upregulation of BDNF expression in the brain. Ablation of afferent nerves from the heart or genetic disruption of neuronal BDNF expression inhibited the increase of plasma BDNF after MI and led to exacerbation of cardiac dysfunction, suggesting a central nervous system-mediated mechanism by which BDNF has a protective effect against cardiac remodeling after MI. These findings also suggest that the activation of neuronal BDNF may become a therapeutic strategy for cardiac disease.
Materials and Methods

Animal Study
The animal experiments were approved by our institutional review board. All mice used in this study were males between 12 and 14 weeks' old unless otherwise indicated. All experimental procedures were performed according to the guidelines established by Chiba University for animal experiments. Mice were anesthetized by intraperitoneal injection of pentobarbital sodium (50 mg/kg), and MI was induced by ligation of the left anterior descending artery as described previously. 10 Generation of conditional knockout mice is described in the online-only Data Supplement.
Physiological and Histological Analysis
Echocardiography was performed with a Vevo 770 High-Resolution Imaging System (Visual Sonics Inc, Toronto, Ontario, Canada). The heart rate was kept at ≈500 to 600 bpm to minimize data deviation when cardiac function was assessed by area length methods. Frozen crosssections (4 µm) of the heart were fixed with 4% 10N formaldehyde and subjected to Masson trichrome staining or immunohistochemistry.
Western Blot Analysis
The lysates were resolved by SDS-PAGE. Proteins were transferred to a polyvinylidene difluoride membrane (Millipore, Bedford, MA), which was incubated with the primary antibody followed by antirabbit or anti-mouse IgG conjugated with horseradish peroxidase (Jackson, West Grove, PA).
RNA Analysis
Real-time polymerase chain reaction was performed by using the Light Cycler (Roche) with the Taqman Universal Probe Library and the Light Cycler Master (Roche) according to the manufacturer's instruction.
Cell Culture
Neonatal Wistar rats were purchased from Takasugi Experimental Animal Supply (Tokyo, Japan). Cardiomyocytes were prepared from these neonatal rats and cultured as described previously. 11
Statistical Analysis
Data are shown as the mean±SEM. Comparison among multiple groups was performed by ANOVA with a post hoc Fisher test, whereas comparisons between 2 groups were performed with the unpaired Student t test. A P value <0.05 was considered statistically significant.
Results
BDNF and TrkB Are Expressed by Cardiomyocytes and Activate the Intracellular Signaling Pathways
To investigate the role of BDNF in the adult heart, we first examined the expression of BDNF and its receptor TrkB in cardiomyocytes. Western blot analysis showed that both BDNF and TrkB were expressed by cardiomyocytes ( Figure 1A ). It has been reported that binding of BDNF to TrkB triggers receptor dimerization and autophosphorylation, followed by the activation of diverse signaling cascades such as the Akt and mitogenactivated protein kinase pathways in neuronal cells. 4 Consistent with these reports, treatment of cardiomyocytes with BDNF rapidly activated these signaling cascades ( Figure 1B ). It was also reported that BDNF exerts a protective effect against neuronal death induced by various stresses such as hypoxia. We therefore exposed cardiomyocytes to hypoxia and examined the influence of BDNF on cell viability. As was the case for neurons, treatment with BDNF decreased hypoxic cardiomyocyte death ( Figure 1C and 1D), and this effect was associated with increased expression of prosurvival molecules ( Figure 1E ). These results indicate that BDNF promotes the survival of cardiomyocytes by activating intracellular signaling pathways via TrkB.
Systemic Deletion of BDNF Leads to Exacerbation of Cardiac Dysfunction After MI
To further investigate the role of BDNF in the heart, we generated conditional BDNF knockout mice using the inducible Cre-loxP system. We prepared transgenic mice in which a transgene encoding Cre recombinase fused to the mutated estrogen receptor domain (Cre-ER) was driven by the cytomegalovirus enhancer/chicken actin (CAG) promoter. We then crossed these CAG-Cre-ER mice with mice bearing floxed Bdnf alleles (CAG-Cre-ER; Bdnf flox/flox mice). In this model, BDNF expression was reduced in various tissues, including the heart and the brain, by treatment with tamoxifen ( Figure 2A ). Consequently, plasma BDNF levels were significantly lower in CAG-Cre-ER; Bdnf flox/flox mice than in their control littermates ( Figure 2B ). CAG-Cre-ER; Bdnf flox/flox mice had a normal appearance and viability (data not shown). We then produced MI in these mice and performed physiological and histological examinations at 2 weeks after surgery. Echocardiography revealed that the left ventricular diastolic dimension was increased and the left ventricular ejection fraction was decreased in CAG-Cre-ER; Bdnf flox/flox mice compared with control littermates ( Figure 2C ). These mice also showed a larger fibrotic area than their control littermates ( Figure 2D ). Histological examination demonstrated that the number of terminal deoxynucleotidyl transferase -mediated dUTP nick-end labeling-positive cardiomyocytes was significantly increased in CAG-Cre-ER; Bdnf flox/flox mice ( Figure 2E ). This increase was associated with impaired vascularization of the border zone of the infarcted region in CAG-Cre-ER; Bdnf flox/flox mice ( Figure 2F ). Consistent with this observation, the expression of vascular endothelial growth factor was lower in the hearts of CAG-Cre-ER; Bdnf flox/flox mice after MI ( Figure 2G ). Indeed, the expression of the proapoptotic molecule Bax was increased, whereas the expression of the prosurvival molecules such as Bcl-2 was decreased in the hearts of CAG-Cre-ER; Bdnf flox/flox mice after MI compared with control littermates ( Figure 2G ). These results suggest that BDNF plays a protective role in the heart after MI by inducing angiogenesis as well as by upregulating the expression of prosurvival factors. August 2012
Disruption of Cardiac TrkB But Not BDNF Exacerbates Systolic Dysfunction After MI
Because BDNF is known to predominantly bind to and activate TrkB, 2 its cardioprotective effect after MI may be mediated by TrkB expressed on cardiomyocytes. To investigate the role of TrkB in the MI heart, we generated cardiomyocytespecific TrkB conditional knockout mice by using the inducible Cre-loxP system. We prepared transgenic mice in which a transgene encoding Cre recombinase fused to the mutated estrogen receptor domains (MerCreMer) was driven by the cardiomyocyte-specific α-myosin heavy chain (MHC) promoter. We then crossed these MHC-MerCreMer mice with mice bearing floxed TrkB alleles and produced MI in these mice (MHC-MerCreMer; TrkB flox/flox mice). In this model, treatment with tamoxifen induced Cre-mediated recombination of floxed TrkB alleles in cardiomyocytes, resulting in specific ablation of cardiac TrkB. Although the basal expression of TrkB was undetectable in the heart, its expression was markedly upregulated after MI in wild-type mice ( Figure 3A ). This upregulation was attenuated in the heart of MHC-MerCreMer; TrkB flox/flox mice after MI ( Figure 3A) . Similarly, the expression of TrkB was strikingly increased in the border zone of the infarcted region in control littermates, but not in MHC-MerCreMer; TrkB flox/flox mice ( Figure 3B ). These results indicate that myocardial ischemia mainly upregulates TrkB expression in cardiomyocytes. MHC-MerCreMer; TrkB flox/flox mice had a normal heart size and systolic function under basal conditions ( Figure 3C ). Two weeks after MI, however, these mice had slightly larger left ventricular diastolic dimension than control littermates ( Figure 3C ). Systolic function was significantly decreased in MHC-MerCreMer; TrkB flox/flox mice compared with their control littermates ( Figure 3C ). These mice also had a larger fibrotic area with more terminal deoxynucleotidyl transferase -mediated dUTP nick-end labeling-positive cardiomyocytes than their control littermates ( Figure 3D and 3E To determine the role of BDNF in the MI heart, we generated cardiomyocyte-specific BDNF conditional knockout mice by using the inducible Cre-loxP system (MHC-MerCreMer; Bdnf flox/flox mice). We created MI in these mice and then performed echocardiography and histological examination. MHC-MerCreMer; Bdnf flox/flox mice had a normal heart size and systolic function under basal conditions ( Figure 4A) . In contrast to MHC-MerCreMer; TrkB flox/flox mice, ablation of BDNF in cardiomyocytes did not affect cardiac remodeling and systolic dysfunction after MI ( Figure 4A ). Moreover, cardiac ablation of BDNF did not attenuate vascularization of the border zone of the infarcted region ( Figure IB in the online-only Data Supplement) nor did it increase infarct size ( Figure 4B ). We found that the cardiac expression of BDNF was markedly downregulated after MI ( Figure 4C ), whereas plasma BDNF levels were significantly increased in wild-type controls ( Figure 5A ). These results suggest that tissues outside the heart increase production of BDNF after MI and that circulating BDNF protects the heart against ischemic injury.
Ablation of Afferent Nerves From the Heart Leads to Exacerbation of Cardiac Dysfunction After MI
Given the important role of BDNF in the nervous system, we hypothesized that BDNF derived from the brain might contribute to its protective effect on the heart after MI. Consistent with this notion, the expression of BDNF was significantly increased in the forebrain including the thalamus and the hypothalamus after MI ( Figure 5B and 5C ). This increase was abolished in the brain of CAG-Cre-ER; Bdnf flox/flox mice (systemic deletion model; Figure 5B ). Similarly, plasma BDNF levels after MI were significantly lower in CAG-Cre-ER; Bdnf flox/flox mice than in wild-type controls ( Figure 5A ). These results led us to propose a novel mechanism whereby the brain senses ischemia in the heart and increases production of BDNF, after which circulating BDNF in turn protects the heart against ischemic injury. There is evidence that cardiac afferent nerve fibers convey mechanosensitive and chemosensitive information to the brain, leading to the activation of various signaling pathways in the CNS. 12 Activation of these CNS pathways has been suggested to play an important role in regulating cardiac function after MI. 13, 14 To determine whether such neuronal pathways convey stimuli from the MI heart to the brain, we treated the heart with capsaicin (CAP), an agonist for transient receptor potential vanilloid type 1 channel that is predominantly expressed on the terminals of primary sensory neurons. 15 CAP treatment leads to an influx of cations by activating transient receptor potential vanilloid type 1 and thereby damages afferent sensory neurons. 15, 16 Histological examination revealed that treatment with CAP effectively ablated primary afferent neurons from the heart ( Figure IIA in the online-only Data Supplement). We then produced MI in mice treated with CAP and examined the influence of ablation of cardiac afferent fibers. Treatment with CAP did not alter the neuronal expression of BDNF in sham-operated mice compared with untreated mice ( Figure 5B ). In contrast, neuronal expression of BDNF after MI was significantly reduced by treatment with CAP ( Figure 5B) . Similarly, ablation of cardiac afferent fibers inhibited the increase of plasma BDNF after MI ( Figure 5A ). Histological examination demonstrated impaired vascularization of the border zone of the infarcted region in CAP-treated mice ( Figure IIB in the online-only Data Supplement). Consequently, cardiac function after MI was significantly worse in CAP-treated mice than in untreated mice ( Figure 5D ). CAP-treated mice had a larger fibrotic area than untreated mice ( Figure 5D ). Peripheral administration of BDNF significantly restored the cardiac phenotype of CAP-treated mice ( Figure IIC in the online-only Data Supplement). These results indicate that cardiac afferent fibers mediate upregulation of BDNF in the brain and that this upregulation protects the infarcted heart against ischemic injury.
Genetic Disruption of Neuronal BDNF Expression Promotes Cardiac Remodeling After MI
To examine the effect of reduced BDNF expression in the brain on cardiac function after MI, we generated brain-specific BDNF conditional knockout mice by crossing nestin-Cre mice with Bdnf flox/flox mice. As previously demonstrated by a study on another type of brain-specific BDNF conditional mutant, 17 nestin-Cre; Bdnf flox/flox mice were viable and hyperactive. In these mice, the neuronal expression of BDNF was markedly reduced and its plasma levels were significantly lower than in control littermates ( Figure 6A and 6B) . Moreover, upregulation of neuronal expression of BDNF and the plasma BDNF levels after MI did not occur in these mice ( Figure 6B and 6C) . Echocardiography revealed that the left ventricular diastolic dimension was increased and the left ventricular ejection fraction was decreased in Nestin-Cre; Bdnf flox/flox mice compared with control littermates (Figure 6D ). Nestin-Cre; Bdnf flox/flox mice also had a larger area of myocardial fibrosis than control littermates ( Figure 6E ). Peripheral administration of BDNF significantly increased its plasma levels ( Figure  III in the online-only Data Supplement) and restored the cardiac phenotype of Nestin-Cre; Bdnf flox/flox mice ( Figure 6D and 6E ), suggesting a crucial role of neuronal BDNF production in protection against cardiac dysfunction after MI.
Discussion
We have demonstrated a CNS-mediated mechanism involved in the regulation of cardiac function after MI. Our results suggest that ischemic insults are transmitted from the heart to the CNS via cardiac afferent nerve fibers after MI, thereby increasing the neuronal expression of BDNF. An increase in circulating BDNF promotes the survival of cardiomyocytes and is associated with increased expression of prosurvival and proangiogenic factors. In agreement with our data, recent evidence has suggested the potential importance of humoral heart-brain signaling in the pathogenesis of heart failure. 13, 14 Accordingly, the CNS may function as a conductor that integrates input signals from a variety of sources, including the failing heart, which in turn leads to activation of certain CNS pathways. Peripheral responses elicited by CNS activation may play an important role in the progression or prevention of cardiac remodeling after MI. Several lines of evidence indicate that the forebrain, in particular the paraventricular nucleus of the hypothalamus, can sense signals generated peripherally in response to the stress of heart failure. 13, 18, 19 Neuronal activation in this area has been shown to enhance calcium-dependent signals and increase oxidative stress. 13, 18, 19 It has also been reported that the BDNF expression is regulated by various transcription factors such as the calcium-response factor, the nuclear factor of T cells, and the nuclear factor κB, which could respond to these changes. 20 Moreover, Rasmussen et al 21 demonstrated a significant output of BDNF across the human and murine brain, which was further enhanced by exercise. Taken together with these reports, our results suggest that cardiac injury activates these CNS pathways, thereby increasing the cerebral output of BDNF.
It has been suggested that decreased neural production of BDNF is a common factor in neurodegenerative diseases such as Alzheimer disease and various psychiatric disorders including major depression, 3 and several studies have demonstrated that patients with such diseases have low circulating levels of BDNF. 3 It has also been reported that BDNF release from the brain is attenuated by hyperglycemia in humans and that reduced plasma BDNF levels are associated with impaired glucose metabolism. 22 Neuropsychiatric diseases and metabolic disorders are highly prevalent among patients with MI and are associated with a significant increase in mortality. 23, 24 These reports led to the hypothesis that a decrease in BDNF may contribute to a poor prognosis among patients with ischemic heart disease and that BDNF-based therapy could be particularly effective for MI patients complicated by the above-mentioned disorders.
In conclusion, our results indicate that an intriguing mechanism underlying the cardioprotective effect of BDNF involves a CNS-mediated pathway and suggest that activation of this pathway could become a novel strategy for the treatment of cardiac dysfunction after MI. 
